Description

Flupentixol & Melitracen Film-Coated Tablets (0.5 mg / 10 mg)

Healthy Inc is a specialized global supplier and exporter of advanced psychiatry, neuro-pharmacology, and complex psychosomatic therapeutics. We provide ultra-high-purity, kinetically synchronized Flupentixol & Melitracen Film-Coated Tablets (0.5 mg / 10 mg), manufactured in WHO–GMP certified, high-precision micro-dosing oral solid dosage facilities. This “Biphasic Neuroleptic & Thymoleptic FDC” is a massive-volume, highly lucrative export to psychiatric clinics, gastroenterology networks (for IBS), general medicine wards, and government health ministries in LATAM, the CIS, Africa, and Southeast Asia, serving as the globally mandated, rapid-onset intervention for psychogenic depression, psychosomatic affections, and severe menopausal anxiety.

Product Overview

This highly advanced formulation operates as a rapid-acting, dual-pathway mood elevator and anxiety stabilizer. Unlike standard SSRIs that take 4 to 6 weeks to work, this specific combination acts within days, physically altering dopamine, serotonin, and norepinephrine levels to rapidly resolve both the mental and physical symptoms of severe stress.

The “Presynaptic Dopamine Modulator & Monoamine Reuptake” Specialist:

• Mechanism 1 (The Activating Neuroleptic – Flupentixol): Flupentixol is a thioxanthene antipsychotic. However, at the microscopic dose of 0.5 mg, it acts completely differently than it does at high doses. At this micro-level, it preferentially blocks presynaptic dopamine D2 autoreceptors. By blocking the receptor that normally tells the brain to “stop” making dopamine, it actually forces the brain to release more dopamine. This provides a rapid, activating, and anti-anxiety effect, instantly lifting the patient out of severe apathy and fatigue.
• Mechanism 2 (The Biphasic Antidepressant – Melitracen): Melitracen is a highly tolerable Tricyclic Antidepressant (TCA). It aggressively inhibits the reuptake of Serotonin and Norepinephrine in the synaptic cleft. It acts as a powerful mood elevator (thymoleptic) that neutralizes the underlying depressive state without the severe, heavy sedation common to older TCAs like Amitriptyline.
• The “Psychosomatic” Synergy: When a patient is severely anxious, their body attacks itself, causing irritable bowel syndrome (IBS), unexplained chest pain, and chronic tension headaches (Masked Depression). The activating dopamine surge of Flupentixol combined with the mood-lifting properties of Melitracen rapidly cuts the communication line between mental stress and physical pain, making it a favorite among general physicians and gastroenterologists.

Product Composition & Strength

We supply this product as a Precision-Blended, High-Density Microdose FDC Tablet, packed exclusively in highly secure, light-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the highly photolabile thioxanthene derivative.

*Pack Sizes: 10×10 Blisters (Optimized specifically for rapid-response, short-to-medium term psychiatric and general medicine dispensing regimens).

Technical & Logistics Specifications

Critical data for Pharmaceutical Importers, Psychiatric Distributors, and Hospital Procurement Boards.

Manufacturing Authority

Marketed and Distributed by Healthy Inc from WHO-GMP & ISO 9001:2015 certified units.

• Ultra-Microdose Content Uniformity & EPS Prevention (CRITICAL COMPLIANCE): The engineering challenge of this FDC defines its safety. Standard generic manufacturers struggle to blend an ultra-potent 0.5 mg active ingredient evenly. If Content Uniformity fails, a patient could ingest an accidental 1.5 mg or 2.0 mg pocket of Flupentixol, instantly triggering Extrapyramidal Symptoms (EPS)—severe muscle spasms, locked jaws, and terrifying restlessness (akathisia). Our psychiatric suites utilize elite dry-blending, geometric dilution, and intensive HPLC batch-testing to guarantee 100% uniformity. This proves to major hospital boards that our dosing is clinically flawless and safe.

Therapeutic Indications (Human Use)

Indicated for the targeted, rapid management of severe anxiety, masked depression, and somatic disorders:

• Psychosomatic Disorders: Unexplained physical pain, gastrointestinal distress (IBS), or cardiac palpitations driven entirely by severe underlying anxiety and stress.
• Psychogenic Depression: Mild to moderate depression accompanied by severe apathy, fatigue, and lack of initiative.
• Menopausal Anxiety: Severe emotional lability, anxiety, and depressive symptoms associated with the menopausal transition.

Dosage & Administration

Recommended Dosage (Strictly as per Physician Guidelines):

• Standard Adult Dosing: Typically 1 tablet in the morning and 1 tablet at noon. Severe cases may require 2 tablets in the morning.
• Administration (The Insomnia Rule): MUST NOT be taken in the late afternoon or evening. Because the 0.5 mg dose of Flupentixol is highly activating, taking this drug before bed will trigger severe, intractable insomnia.
• Duration of Therapy: Designed for rapid response; if no clinical improvement is seen within 1 week, the therapy should be reassessed.

Safety Warnings (CRITICAL Regulatory & Clinical Data):

• Extrapyramidal Symptoms (EPS) & Tardive Dyskinesia: Even at micro-doses, long-term use can trigger Parkinsonian tremors, muscle rigidity, and potentially irreversible Tardive Dyskinesia (involuntary facial and tongue movements). Routine neurological monitoring is required.
• Cardiac Arrhythmias & QT Prolongation: Melitracen can cause severe, fatal cardiac arrhythmias. It is strictly contraindicated in patients with a recent myocardial infarction, bundle-branch block, or severe preexisting cardiovascular disease.
• BLACK BOX WARNING (Suicidal Ideation): Like all antidepressants, this FDC increases the risk of suicidal thinking and behavior in young adults. Psychiatric monitoring is mandatory.
• MAOI Contraindication (FATAL): Absolutely contraindicated for use within 14 days of taking Monoamine Oxidase Inhibitors (MAOIs) due to the risk of fatal Serotonin Syndrome and hypertensive crises.
• Severe Agitation Contraindication: Because this combination is “activating,” it is strictly contraindicated in patients suffering from extreme psychomotor agitation, acute mania, or severe aggressive states, as it will violently worsen their symptoms.

Global Export & Contract Manufacturing Services

Healthy Inc stands as a premier Pharmaceutical Exporter in India, dedicated to serving international Pharma Traders, Wholesalers, and Psychiatry Networks. As a verified Medicine Supplier in Mumbai, we offer flexible Third Party Manufacturing (Contract Manufacturing) services for Advanced Antidepressants, Anxiolytics, and Ultra-Microdose Content-Uniformity Assured Formulations. Whether you are looking for a reliable Government Tender Supplier for general medicine wards in Southeast Asia or a B2B Pharma Marketplace partner for the CIS, our highly regulated logistics network ensures timely, secure delivery of WHO-GMP certified products.